Monthly information on share capital and company voting rights
Rhea-AI Summary
Cellectis has released its monthly share capital and voting rights information as of November 30, 2024. The company reported a total of 100,093,873 shares in the capital and 88,576,206 voting rights. This disclosure is made in accordance with Article 223-16 of the General Regulation of the French financial markets authority, with the company's shares listed on Euronext Growth under ISIN code FR0010425595.
Positive
- None.
Negative
- None.
News Market Reaction – CLLS
On the day this news was published, CLLS gained 4.76%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
(Article 223-16 of General Regulation of the French financial markets authority)
PARIS, Dec. 04, 2024 (GLOBE NEWSWIRE) --
Listing market: Euronext Growth
ISIN code: FR0010425595
| Date | Total number of shares in the capital | Total number of voting rights |
| 11/30/2024 | 100,093,873 | 88,576,206 |
For further information on Cellectis, please contact:
Media contact:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93
Investor Relations contacts:
Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com
Attachment
FAQ
How many shares does Cellectis (CLLS) have as of November 30, 2024?
What is the total number of voting rights for Cellectis (CLLS) as of November 2024?
On which exchange are Cellectis (CLLS) shares listed?
